MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 9, 2005; DOI: 10.1124/mol.104.008342


0026-895X/05/6705-1493-1504$20.00
Mol Pharmacol 67:1493-1504, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.104.008342v1
67/5/1493    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, J. A.
Right arrow Articles by Rasenick, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, J. A.
Right arrow Articles by Rasenick, M. M.
ORIGINAL ARTICLE

{beta}-Adrenergic Receptor Stimulation Promotes G{alpha}s Internalization through Lipid Rafts: A Study in Living Cells{boxs}

John A. Allen, Jiang Z. Yu, Robert J. Donati, and Mark M. Rasenick

Departments of Physiology & Biophysics (J.A.A., J.Z.Y., R.J.D., M.M.R.) and Psychiatry (M.M.R), University of Illinois at Chicago, College of Medicine, Chicago, Illinois

Abstract

Upon binding hormones or drugs, many G protein-coupled receptors are internalized, leading to receptor recycling, receptor desensitization, and down-regulation. Much less understood is whether heterotrimeric G proteins also undergo agonist-induced endocytosis. To investigate the intracellular trafficking of G{alpha}s, we developed a functional G{alpha}s-green fluorescent protein (GFP) fusion protein that can be visualized in living cells during signal transduction. C6 and MCF-7 cells expressing G{alpha}s-GFP were treated with 10 µM isoproterenol, and trafficking was assessed with fluorescence microscopy. Upon isoproterenol stimulation, G{alpha}s-GFP was removed from the plasma membrane and internalized into vesicles. Vesicles containing G{alpha}s-GFP did not colocalize with markers for early endosomes or late endosomes/lysosomes, revealing that G{alpha}s does not traffic through common endocytic pathways. Furthermore, G{alpha}s-GFP did not colocalize with internalized {beta}2-adrenergic receptors, suggesting that G{alpha}s and receptors are removed from the plasma membrane by distinct endocytic pathways. Nonetheless, activated G{alpha}s-GFP did colocalize in vesicles labeled with fluorescent cholera toxin B, a lipid raft marker. Agonist significantly increased G{alpha}s protein in Triton X-100 –insoluble membrane fractions, suggesting that G{alpha}s moves into lipid rafts/caveolae after activation. Disruption of rafts/caveolae by treatment with cyclodextrin prevented agonist-induced internalization of G{alpha}s-GFP, as did overexpression of a dominant-negative dynamin. Taken together, these results suggest that receptor-activated G{alpha}s moves into lipid rafts and is internalized from these membrane microdomains. It is suggested that agonist-induced internalization of G{alpha}s plays a specific role in G protein-coupled receptor-mediated signaling and could enable G{alpha}s to traffic into the cellular interior to regulate effectors at multiple cellular sites.


Received October 17, 2004; accepted February 9, 2005

Address correspondence to: Dr. Mark M. Rasenick, Department of Physiology and Biophysics (MC 901), College of Medicine, University of Illinois at Chicago (UIC), 835 South Wolcott Avenue, Chicago, IL 60612–7342. E-mail: raz{at}uic.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. J. Donati, Y. Dwivedi, R. C. Roberts, R. R. Conley, G. N. Pandey, and M. M. Rasenick
Postmortem Brain Tissue of Depressed Suicides Reveals Increased Gs{alpha} Localization in Lipid Raft Domains Where It Is Less Likely to Activate Adenylyl Cyclase
J. Neurosci., March 19, 2008; 28(12): 3042 - 3050.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. P. Atshaves, A. L. McIntosh, H. R. Payne, A. M. Gallegos, K. Landrock, N. Maeda, A. B. Kier, and F. Schroeder
SCP-2/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes
J. Lipid Res., October 1, 2007; 48(10): 2193 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. F. El-Yazbi, W. J. Cho, R. Schulz, and E. E. Daniel
Caveolin-1 knockout alters beta-adrenoceptors function in mouse small intestine
Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1020 - G1030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Yumoto, H. Nishikawa, M. Okamoto, H. Katayama, J. Nagai, and M. Takano
Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L946 - L955.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. Freudzon, R. P. Norris, A. R. Hand, S. Tanaka, Y. Saeki, T. L.Z. Jones, M. M. Rasenick, C. H. Berlot, L. M. Mehlmann, and L. A. Jaffe
Regulation of meiotic prophase arrest in mouse oocytes by GPR3, a constitutive activator of the Gs G protein
J. Cell Biol., October 24, 2005; 171(2): 255 - 265.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. Afshar, F. S. Willard, K. Colombo, D. P. Siderovski, and P. Gonczy
Cortical localization of the G{alpha} protein GPA-16 requires RIC-8 function during C. elegans asymmetric cell division
Development, October 15, 2005; 132(20): 4449 - 4459.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics